The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Journal: Evidence-based Cardiology. 2012;(3): 5‑10

Read: 3726 times

Download PDF (RU)
Contact the author
Table of contents

To cite this article:

. Evidence-based Cardiology. 2012;(3):5‑10. (In Russ.)

МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Abstract:

Close metadata

References:

  1. Hochman J.S., Sleeper L.A., Webb J.G., et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. N Engl J Med 1999;341:625-634.
  2. Babaev A., Frederick P.D., Pasta D.J., et al. Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. JAMA 2005;294:448-454.
  3. Goldberg R.J., Spencer F.A., Gore J.M., et al. Thirty-year trends (1975 to 2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction: a population-based perspective. Circulation 2009;119:1211-1219.
  4. Jeger R.V., Radovanovic D., Hunziker P.R., et al. Ten-year incidence and treatment of cardiogenic shock. Ann Intern Med 2008;149:618-626.
  5. Thiele H., Allam B., Chatellier G., et al. Shock in acute myocardial infarction: the Cape Horn for trials? Eur Heart J 2010;31:1828-1835.
  6. Antman E.M., Anbe D.T., Armstrong P.W., et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction - executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation 2004;110:588-636. [Erratum, Circulation 2005;111:2013.]
  7. Van de Werf F., Bax J., Betriu A., et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 2008;29:2909-2945.
  8. Wijns W., Kolh P., Danchin N., et al. Guidelines on myocardial revascularization. Eur Heart J 2010;31:2501-2555.
  9. Sjauw K.D., Engstroöm A.E., Vis M.M., et al. A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: should we change the guidelines? Eur Heart J 2009;30:459-468.
  10. Prondzinsky R., Lemm H., Swyter M., et al. Intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP SHOCK Trial for attenuation of multiorgan dysfunction syndrome. Crit Care Med 2010;38:152-160.
  11. Thiele H., Schuler G., Neumann F.-J., et al. Intraaortic balloon counterpulsation in acute myocardial infarction complicat- ed by cardiogenic shock: design and rationale of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial. Am Heart J 2012;163:938-945.
  12. Werdan K., RuΒ M., Buerke M., et al. Cardiogenic shock due to myocardial infarction: diagnosis, monitoring and treatment - a German-Austrian S3 Guideline. Dtsch Arztebl Int 2012;109:343-351.
  13. Le Gall J.R., Lemeshow S., Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993;270:2957-2963.
  14. The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993;329:673-682.
  15. Hochman J.S. Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm. Circulation 2003;107:2998-3002.
  16. Scheidt S., Wilner G., Mueller H., et al. Intra-aortic balloon counterpulsation in cardiogenic shock - report of a cooperative clinical trial. N Engl J Med 1973;288:979-984.
  17. Prondzinsky R., Unverzagt S., Russ M., et al. Hemodynamic effects of intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP SHOCK trial. Shock 2012;37:378-384.
  18. Abdel-Wahab M., Saad M., Kynast J., et al. Comparison of hospital mortality with intra-aortic balloon counterpulsation insertion before versus after primary percutaneous coronary intervention for cardiogenic shock complicating acute myocardial infarction. Am J Cardiol 2010;105:967-971.
  19. Patel M.R., Smalling R.W., Thiele H., et al. Intra-aortic balloon counterpulsation and infarct size in patients with acute anterior myocardial infarction without shock: the CRISP AMI randomized trial. JAMA 2011;306:1329-1337.
  20. Cheng J.M., den Uil C.A., Hoeks S.E., et al. Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials. Eur Heart J 2009;30:2102-2108.
  21. Wilson S.R., Mudge G.H. Jr, Stewart G.C., Givertz M.M. Evaluation for a ventricular assist device: selecting the appropriate candidate. Circulation 2009;119:2225-2232.
  22. Unverzagt S., Machemer M.T., Solms A., et al. Intra-aortic balloon pump counter- pulsation (IABP) for myocardial infarction complicated by cardiogenic shock. Cochrane Database Syst Rev 2011;7:CD007398.
  23. Thiele H., Lauer B., Hambrecht R., et al. Reversal of cardiogenic shock by percutaneous left-atrial-to-femoral arterial bypass assistance. Circulation 2001;104:2917-2922.
  24. Thiele H., Sick P., Boudriot E., et al. Randomized comparison of intra-aortic balloon support versus a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock. Eur Heart J 2005;26:1276-1283.
  25. Fincke R., Hochman J.S., Lowe A.M., et al. Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: a report from the SHOCK trial registry. J Am Coll Cardiol 2004; 44:340-348.
  26. Prondzinsky R., Unverzagt S., Lemm H., et al. Interleukin-6, -7, -8 and -10 predict outcome in acute myocardial infarction complicated by cardiogenic shock. Clin Res Cardiol 2012;101:375-384.
  27. The TRIUMPH Investigators. Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: the TRIUMPH randomized controlled trial. JAMA 2007;297:1657-1666.
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.